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Abstract 
Background and Aims: Intestinal fibrosis is a complication of inflammatory bowel disease (IBD). 
Although fibrostenosis is a rare event in ulcerative colitis (UC), there is evidence that a fibrotic 
rearrangement of colon occurs in the later stages. This is a retrospective study aimed at examining 
the histopathological features of colonic wall in both short-lasting (SL) and long-lasting (LL) UC. 
Methods: Surgical samples of left colon from non-stenotic SL (≤ 3 years, n=9) and LL (≥ 10 years, 
n=10) UC patients with active disease were compared to control colonic tissues from cancer 
patients without UC (n=12) to assess: collagen and elastic fibers by histochemistry; vascular 
networks (CD31/CD105/nestin) by immunofluorescence; parameters of fibrosis [type I and III 
collagen, fibronectin, RhoA, alpha-smooth muscle actin (α-SMA), desmin, vimentin] and 
proliferation [proliferating nuclear antigen (PCNA)] by Western blot and/or immunolabelling. 
Results: Colonic tissue from both SL-UC and LL-UC showed tunica muscularis thickening and 
transmural activated neovessels (displaying both proliferating CD105-positive
 
endothelial cells and 
activated nestin-positive
 
pericytes), as compared to controls. In LL-UC the increased collagen 
deposition was associated with an up-regulation of tissue fibrotic markers (collagen I and III, 
fibronectin, vimentin, RhoA), an enhancement of proliferation (PCNA) and, along with a loss of 
elastic fibers, a rearrangement of the tunica muscularis towards a fibrotic phenotype. 
Conclusions: A significant transmural fibrotic thickening occurs in colonic tissue from LL-UC, 
together with a cellular fibrotic switch in the tunica muscularis. A full-thickness angiogenesis is 
also evident in both SL- and LL-UC with active disease, as compared to controls. 
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INTRODUCTION
 
Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) with an increasing 
incidence in western countries, associated with different degree of short/long-term disabilities due 
to intestinal dysmotility and symptoms such as abdominal pain, diarrhoea, and altered 
evacuation.
1,2 
Althought the etiology of UC is unknown, it results from a dysregulated immune 
response with tissue damage occurring in the large bowel, with complications that are increasingly 
attracting the interest of researchers and clinicians.
3,4,5,6
 
In the setting of chronic intestinal inflammation, abnormal tissue repair may occur, and lead 
to intestinal fibrosis and strictures with consequent serious clinical problems, which affect mainly 
Crohn’s disease patients. Intestinal fibrosis is viewed as a long-lasting healing process of the gut 
that results from both an increased and altered deposition of extracellular matrix (ECM) together 
with a reduced breakdown of ECM components.
4,7 
These fibrotic rearrangements have been largely 
overlooked in UC, since it is acknowledged as an inflammatory disease confined to the 
mucosal/submucosal layers, which can develop strictures infrequently (1-10%), as compared to 
Crohn’s disease.8,7 Not surprisingly, besides muscular hypertrophy, regarded as responsible for the 
development of strictures in UC, a consistent fibrotic deposition has been reported also in UC: in 
particular, a transmural collagen enhancement has been demonstrated in UC,
9
 regardless of disease 
duration.
10 
When considering the cellular components that contribute to fibrogenesis in the inflamed 
bowel, recent studies suggest the involvement of smooth muscle cells (SMCs) and cells of vascular 
origin.
11,12,13,14 
In particular, in the setting of bowel inflammation, the occurrence of endothelial-to-
mesenchymal transition has been described as a novel mechanism of intestinal fibrosis, thus 
suggesting that collagen-producing cells may stem also from transformation of non-mesenchymal 
cells.
14,15
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 Although strictures are known to affect low proportions of UC patients, usually over the 
course of long-standing disease, considering the important clinical consequences of colonic fibrotic 
deposition even in the absence of strictures,
 
histopathological studies in non-stenotic UC during the 
time-course of the disease are highly expected.
7
  
Based on the above background, the present study was designed to evaluate whether 
histological and molecular signs of fibrotic and vascular remodelling can be documented in the 
inflamed colonic wall of patients with short-lasting (SL) and long-lasting (LL) UC, without clinical 
evidence of obstruction related to strictures. 
 
PATIENTS AND METHODS  
Patients selection 
Full-thickness samples of left (descending and sigmoid) colon were retrieved from UC 
patients with active, pharmacologically unresponsive disease, without clinical symptoms of 
fibrostenosis, who had undergone elective bowel resection due to a severe exacerbation of colitis. 
Based on the disease duration after the UC diagnosis (colectomy within 3 years or after 10 years), 
patients were allocated to two subgroups, designated as SL (n=9, 6 males and 3 females, age range 
22-74 years) and LL (n=10, 5 males and 5 females, age range 41-77 years) UC. The following 
clinical and pathological criteria were assessed for each subgroup: mean disease duration; disease 
extension (ulcerative proctitis, left-sided UC, extensive UC); histological inflammation grade, 
estimated by the Geboes’ score as descripted below; clinical symptoms (stool frequency, rectal 
bleeding and abdominal pain). Stool frequency was assessed in accordance with the grading of 
Sutherland and Martin
16 
: 0= normal; 1= 1-2 stools/day>normal, 2= 3-4 stools/day>normal, 3= >4 
stools/day>normal. Control colonic samples were obtained from 12 subjects (7 males, 5 females; 
age range 37–73 years), who underwent elective surgery for uncomplicated left colon cancer, 
without previous history of abdominal surgery, inflammatory bowel disease or intestinal 
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obstruction. Specimens, including teniae, were taken at least 5 cm far from resection margins in 
tumour free areas. The selection of UC and control patients was based on the availability of both 
frozen and paraffin-embedded colonic tissues archived in the pathology tissue bank. Since the study 
was performed on archival material, no individual patient identification was involved, and no study-
driven clinical intervention was performed. Accordingly, a simplified procedure for Institutional 
Review Board approval was followed. 
Histological evaluation  
Full-thickness colonic samples, formalin-fixed and paraffin-embedded, were serially cross-
sectioned (3 μm-thickness) for each patient. Then, sections were deparaffinized, rehydrated and 
processed for routine haematoxylin/eosin (H&E) staining, histochemical staining for collagen and 
elastic fibers, and immunostaining as follows. 
Histopathology. Inflammatory lesions were scored in accordance with previously described 
histopathological criteria.
17,18
 In particular, the Geboes’ microscopic score was employed to 
estimate the severity and inflammatory activity of UC by evaluation of: structural tissue damage; 
chronic inflammatory infiltrate; presence of eosinophils and/or neutrophils in the lamina 
propria/epithelium; crypt destruction; erosions/ulcerations. The score, with values ranging from 0 
(no inflammation) to 22 (maximum inflammation), was determined on colonic slices in the most 
involved region. 
Histochemistry. Tissue collagen and elastic fiber deposition were evaluated by Sirius 
Red/Fast Green and orcein, as previously reported.
19,20
  
Immunoperoxidase. Slides were incubated overnight at 4°C with primary antibodies, with the 
purpose of detecting matrix fibers by rabbit anti-type I and III collagen ([1:1000]; code: ab34710 
and ab7778, respectively, Abcam, Cambridge, UK) and rabbit anti-fibronectin ([1:10000]; code: 
1574-1, Epitomics, Burlingame, CA, USA. They were then exposed to biotinylated 
immunoglobulins (goat anti-rabbit and anti-mouse ([1:200]; code: BA-1000 and BA-9200, 
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respectively, Vector Lab, Burlingame, USA), peroxidase-labelled streptavidin complex, and 3.3’-
diaminobenzidine tetrahydrochloride (DakoCytomation, Glostrup, Denmark), as previously 
described.
21
 Sections were examinated by a Leica DMRB light microscope, and representative 
photomicrographs were taken by a DFC480 digital camera (Leica Microsystems, Cambridge, UK). 
Immunofluorescence. Double immunolabellings, carried out with cell-specific and 
proliferation markers were analysed by confocal microscopy immunofluorescence.  CD31/PECAM-
1 and von Willebrand factor (vWF) were used as markers of endothelial cells; CD105/endoglin as a 
marker of activated/proliferating endothelial cells; nestin for activated pericytes/mural cells; alpha-
smooth muscle actin (α-SMA) to identify SMCs; proliferating cellular nuclear antigen (PCNA) for 
identifying proliferating cells; cytoskeleton filaments, desmin and vimentin as markers of cell 
phenotype. The primary antibodies were as follows: mouse anti-CD31 ([1:25]; code: M0823, 
DakoCytomation), rabbit anti-CD105 ([prediluted]; code: ab27422, Abcam), mouse anti-nestin 
([1:400]; code: MAB353, Millipore, Billerica, USA), rabbit anti-vWF ([1:400]; code: Ab6994, 
Abcam), mouse anti-PCNA ([1:1000]; Santa Cruz Biotechnology, Inc., Heidelberg, Germany) 
mouse anti-α-SMA ([ready to use] code: 760-2833, Cell Marque, Rocklin, CA, USA), rabbit anti-
desmin ([1:500]; code: ab8592, Abcam), rabbit anti-vimentin ([1:1000]; code: ab92547, Abcam). 
Briefly, sections were sequentially incubated with: 0.5% Triton X-100 (Merck KGaA, Darmstadt, 
Germany) in PBS solution, Protein Block Serum Free (DakoCytomation), combined primary 
antibodies diluted in PBS (overnight at 4°C), revealed by appropriate fluorophore-conjugated 
secondary antibodies (goat anti-mouse Alexa 488 and goat anti-rabbit Alexa 568 ([1:300]; code: A-
11029 and A-11011, respectively; Invitrogen, Eugene, USA) or biotinylated secondary antibody 
(biotinylated goat anti-mouse ([1:200]; code: BA-9200, Vector) followed by Alexa 488 conjugated 
streptavidin ([1:300]; code: S-32354; Invitrogen) followed by nuclear counterstaining with TO-
PRO3 (Invitrogen). Stainings were examined under a Leica TCS SP5 confocal laser-scanning 
microscope (Leica Microsystems, Mannheim, Germany) using a sequential scan procedure. 
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Confocal images were taken at 250-500 nm intervals through the z-axis of sections, by means of 
40x and 63x oil lenses. Z-stacks of serial optical planes were analyzed by confocal software 
(Multicolor Package; Leica Microsystems) as previously described.
22
 Negative controls were 
prepared by omitting the primary antibodies, pre-adsorbing the primary antibodies with an excess of 
antigen when available, and mismatching the secondary antibodies. 
 Vessel quantification. The amount of vessels was calculated by laser confocal microscopy 
using a computer-aided morphometric analysis with the Leica confocal Multicolor Package and 
ImageJ software (NIH, Bethesda, MA, USA). In order to detect vessel profiles from the 
distributions of CD31-positive pixels, only gaps in the stains wider than 2.0 µm were considered to 
be lumens, and only stained objects in the range 4.5 µm to 15 µm wide were considered to be 
microvessels. Microvessel density was calculated considering the percentage area of vessels, which 
was calculated taking into account the total vessel area fraction, lumina included, on the total image 
area, together with the cumulative vessel length (100µm/volume of scanned tissue normalized to 
10
6μm3).23 
Western blot analysis in colonic tissues 
After thawing, full-thickness colonic specimens were dissected to separate mucosa from 
muscle layers and then lysed in RIPA buffer. Homogenates were spun by centrifugation at 20,000 
revolutions/min for 15 min at 4°C, and the resulting supernatants were then separated from pellets 
and stored at -20°C. Protein concentration was determined in each sample by the Bradford method 
(Protein Assay Kit; Bio-Rad Laboratories, Hercules, CA).
 
Aliquots of 30 μg of protein were 
separated by electrophoresis on 8% SDS-polyacrylamide gel electrophoresis and transferred onto a 
poly(vinylidene difluoride) membrane. The blots were then blocked for 1 h with appropriate buffer 
and incubated overnight at room temperature with the following primary antibodies: rabbit anti-type 
I and III collagen ([1:5000]; Abcam); rabbit anti-fibronectin ([1:10000]; Epitomics); rabbit anti-
SMA ([1:1000]; code: ab5694, Abcam); rabbit anti-vimentin ([1:1000]; Abcam); mouse anti-PCNA 
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([1:1000]; Santa Cruz), and rabbit anti-RhoA ([1:1000]; code ARH03, Cytoskeleton, Denver, CO, 
USA). After repeated washings with TBS-T, a goat anti-rabbit and anti-mouse peroxidase-
conjugated secondary antibody ([1:10000]; code: sc2004 and sc2005, respectively, Santa Cruz) was 
added for 1 h at room temperature. After repeated washings with TBS-T, immunoreactive bands 
were visualized by incubation with chemiluminescent reagents (Immobilon reagent; Millipore 
Corporation, Billerica, MA) and exposed to Eastman Kodak (Rochester, NY) Image Station 440 for 
signal and densitometric image analysis. To ensure equal loading and accuracy of changes in 
protein amount, protein levels were normalized to β-actin. 
Image Analysis and Statistics  
Two blind pathologists/histologists quantitatively estimated the inflammatory lesions (DC and 
MC), histochemical data (CS and CI) and vessel density (FG and ME), analyzing the same samples 
by the same standardized procedures of all tissue specimens under study; the respective values were 
then averaged and plotted in graphs as previously reported.
21,20
 Briefly, for each patient, 
microscopic fields captured from 3 non-adjacent sections were analyzed and evaluated by the Image 
Analysis System “L.A.S. software v.4”. Positive areas were expressed as percentage of the total 
tissue area examined (percentage positive pixels [PPP]). Data were expressed as mean ± SEM, 
statistically analysed using one-way ANOVA followed by the appropriate post hoc test 
(Bonferroni’s test) or, when required, Student’s t-test for unpaired data (two tailed). Statistical 
significance was set at P≤0.05. 
 
RESULTS  
The two subgroups of patients, affected by SL-UC and LL-UC, did not differ significantly in 
terms of disease location, clinical symptoms and treatments (Table 1).  
Histopathology 
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All UC specimens displayed typical UC mucosal/submucosal lesions, inflammatory 
infiltration, erosion/ulceration and crypt destruction: a high Geboes’ score was obtained for both 
SL-UC and LL-UC (19.33±1.26 and 21.17±0.40, respectively), without significant differences. A 
significant thickening of tunica muscularis was observed in all UC patients, with a 1.2- and 1.32-
fold increase in SL-UC and LL-UC, respectively, versus controls (1948.42±39.44 μm and 
2060.03±80.06 μm, respectively, versus 1558.34±63.33, P≤0.01) (Fig. 1). Conversely, normal 
morphological patterns were detected in colonic samples from all control subjects, with an intact 
mucosal layer, occasional inflammatory cells, and a well preserved tunica submucosa and 
muscularis (Fig. 1). 
When examining colonic blood vessels, an increased network was observed in all layers of 
both SL-UC and LL-UC samples, as compared with control subjects (Fig. 2). Inflamed tissues 
displayed a higher density of microvessels lined by CD31-positive/CD105-positive activated
 
endothelial cells as well as a network of highly CD31-positive very small vessels (Fig. 2). Notably, 
microvessels of the inflamed colon displayed several proliferating endothelial cells with PCNA-
positive nuclei as well as activation of pericytes/mural cells, which were found to overexpress 
nestin (Fig. 2). The highest increase in vessel density was detected in the tunica muscularis of 
inflamed colon in both SL-UC and LL-UC, which displayed a fold increase of 9.6 and 5.8 versus 
controls, respectively (Table 2). 
Fibrotic changes in UC  
Sirius Red-positive collagen fibers were significantly increased in LL-UC, reaching the 
overall amount of 46.42±3.72 (P≤0.001) in the whole colonic wall, as compared to controls 
(27.41±2.14) and SL-UC (29.89± 0.89). When examining separately the colonic layers, collagen 
deposition in LL-UC was 1.5 folds higher in the tunica mucosa/submucosa and 1.7 folds in the 
tunica muscularis than in controls, and 1.5 folds higher in the tunica mucosa/submucosa and 1.4 
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folds in the tunica muscularis than in SL-UC (Fig. 3). By contrast, orcein-positive elastic fibers 
were significantly reduced in LL-UC displaying a 0.5-fold decrease versus controls (Fig. 4). 
Molecular data showed a significant increase in type I and III collagens and fibronectin, 
within the mucosal and muscle layers, in LL-UC samples as compared to both controls and SL-UC. 
In particular, increased collagen I and III immunostaining was observed at level of the outer layers 
of longitudinal muscle (i.e., serosal side), along which it was arranged as bunches of fibers 
intermingled with bundles of SMCs. Large amounts of fibronectin were found mainly within the 
circular muscle and along the myenteric ridge (Fig. 5). 
Wall remodelling in longstanding UC 
Further studies were focused on tissue and molecular rearrangement of the inflamed colonic 
wall from patients with LL-UC, which resulted more compromised in terms of fibrotic deposition 
as compared with SL-UC. The inflamed tunica muscularis displayed a significant enhancement of 
collagen type I and III, fibronectin, RhoA, PCNA as well as vimentin, the latter being increased 
also in the mucosa (Fig. 5 and 6). By contrast, in LL-UC patients we observed a significant fall in 
α-SMA expression in both the colonic mucosa and tunica muscularis (Fig. 6). Immunofluorescence 
studies on the tunica muscularis showed SMCs displaying an uneven α-SMA staining pattern and 
absence of desmin as well as many vimentin-positive cells; PCNA-positive nuclei were strongly 
stained in several vimentin-positive cells and faintly stained in few α-SMA-positive cells (Fig. 7).  
 
DISCUSSION 
In the present study, we report original findings concerning the comparative analysis of 
histopathologic and molecular alterations occurring in full-thickness colonic specimens of UC 
patients affected by SL and LL active disease, thus providing new insights into the tissue and 
molecular rearrangement of the inflamed colonic wall at different stages of UC. In particular, an 
overall view of our observations indicates that the two subgroups of UC patients displayed two 
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main distinctive features in their inflamed colonic tissues: 1) an increased density of neovessels that 
was evident in both subgroups, although with a significant predominance in SL-UC; 2) a significant 
increase in fibrotic deposition that occurred in LL-UC, but not in SL-UC. 
In our series, the first original finding regards the evidence that, at variance with previous 
studies, which documented the occurrence of angiogenesis in the UC mucosa,
24,25
 the increase in 
vascular density was observed as a full-thickness process in both SL- and LL-UC. Of interest, the 
district most affected by angiogenesis was the muscle layer, where the increase in vasculature 
achieved fold-increments of 9.6 and 5.8 in SL- and LL-UC, respectively, as compared to non-
inflamed control tissues. In agreement with the morphometric analysis, the neovessels observed in 
the inflamed colon showed several signs of activation, such as the presence of proliferating 
CD105/PCNA-positive endothelial cells as well as activated nestin-positive pericytes. Moreover, 
the evidence that the intense network of proliferating microvessels was detected in both UC 
subgroups suggests that it is likely related with the severity of inflammatory activity rather than 
disease duration. Indeed, angiogenesis is regarded as a hallmark of active intestinal inflammation, 
closely related to disease severity, and invariably described in the inflamed bowel mucosa.
26,27,28
 In 
recent years, angiogenesis has gained considerable attention in the pathogenesis of IBD, being 
considered a crucial event in the initiation and progression of bowel inflammation.
15
 However, 
scarce data are currently available on the histological rearrangements of microvessel architecture 
throughout the different layers of the inflamed bowel wall in UC patients. Only when considering 
the colonic mucosa, elegant studies have shown that it is endowed with potent angiogenic activity 
in UC patients,
24
 and that in animal models of colitis a correlation exists between tissue injury and 
the inflammation-driven mucosal angiogenesis.
25
 
With regard to collagen and fibronectin evaluations, we observed significant fibrotic 
deposition throughout the whole thickness of the left colon in LL-UC patients, while only a trend 
towards transmural fibrosis was found in SL-UC. These findings are partly consistent with the 
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fibrotic rearrangement of colonic wall reported in both preclinical models of colitis and UC 
patients, even though some differences can be recognized, depending on the disease activity, 
extension, duration and degree of fibrotic remodelling. In particular, transmural collagen deposition 
has been recently described in experimental models of colitis
12,19,29,30,31 
as well as in UC patients 
with advanced fibrotic disease.
32 
De Bruyn et al.
10 
observed increased full-thickness amounts of 
collagen in the colon of UC patients with both early (< 2 years, with active inflammation) and 
longstanding (> 10 years, without inflammatory activity) disease, without any significant change in 
collagen expression over the time. 
Of interest, besides the increased levels of collagen type I-III and fibronectin, detected in both 
mucosal and muscle layers of LL-UC, we found also an up-regulation of collagen type III in the 
mucosa of SL-UC, this observation being consistent with the condition of active colonic 
inflammation and the high ratio of type III:I collagen described previously in the submucosa of UC 
patients.
9
 Moreover, when considering the increased transmural deposition of fibronectin that we 
observed in LL-UC patients, it is worth mentioning that a similar finding has been reported 
previously for the intestinal fibrosis associated with Crohn’s disease33 and, more recently, for the 
colonic mucosa of LL-UC in the absence of inflammatory activity.
10 
In the present work, another original finding was the loss of elastic fibers observed 
throughout the full-thickness of the inflamed colonic wall in LL-UC, but not SL-UC, patients. Due 
to the mechanical properties of elastin, that allows tissues to recoil after repeated stretching, the 
reduced presence of elastic fibers may result in defects of the elastic properties of bowel wall, thus 
contributing to worsen further the condition of bowel dysmotility that occurs often in IBD and is 
thought to be primarily associated with alterations of neuromuscular cell components.
21,32,34,35,36 
 
 
Although UC is known to evolve towards fibrostenosis with much lower frequency than 
Crohn’s disease (1-10%), particularly in patients with long-lasting disease,8,11,37 with important 
clinical consequences, such as severe bowel dysmotility,6,38, ni t is important to consider that fibrotic 
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strictures result from slow-rate processes, supported by chronic inflammation and long-lasting 
tissue remodelling. On this basis, we deemed it interesting to focus the second part of this study on 
LL-UC, which was found to be mostly affected by collagen deposition and loss of elastic fibers, in 
order to examine whether molecular and cellular colonic remodelling occur in the advanced stages 
of disease. 
At level of the tunica muscularis, in addition to increments of collagens and fibronectin, in 
the inflamed colon of LL-UC patients we detected an upregulation of vimentin, a decrease in α-
SMA and desmin, along with abundant proliferating PCNA-positive cells, as compared to non-
inflamed controls. Interestingly, we observed a diffuse phenotype modulation of cells within the 
tunica muscularis. In particular, the quiescent, non-proliferative (PCNA-negative) smooth muscle 
cell phenotype (α-SMA-positive/desmin-positive/vimentin-negative) was replaced by proliferative 
myofibroblast-like (reduced, deranged α-SMA/desmin-negative/vimentin-negative) and several 
proliferative fibroblast-like (α-SMA-negative/desmin-negative/vimentin-positive) phenotypes. In 
keeping with data reported by in vitro and in vivo studies on enteric muscle layers in experimental 
colitis, 
12,13,19
 the fibrogenic phenotypic rearrangement, as observed in the present study, provides 
evidence in humans that, under inflammatory conditions, the tunica muscularis undergoes a cellular 
fibrotic switch, which, along with collagen deposition and elastin loss, may contribute to 
impairments of its motor functions. Interestingly, insightful observations, made in in vitro studies, 
suggest that stiffness of intestinal tissues can trigger morphological and functional changes in 
human colonic fibroblasts and myofibroblasts, from a non-proliferative to an activated fibrogenic 
myofibroblast phenotype.
39,40
 In this light, a stiff ECM could be considered not as a result, but 
rather as a source of tissue fibrosis
 
in IBD, with a critical role in supporting the development and 
progression of fibrogenesis. 
Our data on the fibrotic switch of inflamed smooth muscle in LL-UC are strengthened by the 
finding of an up-regulation of RhoA expression in muscle layers. Indeed, there is consistent 
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evidence supporting an important role of the Rho/Rho kinase pathway in the determinism of 
intestinal fibrosis.
41
 In particular, RhoA signaling plays a relevant role in the fibrogenic 
differentiation of intestinal SMCs both in human radiation enteritis
42 
and in in vitro models of 
human intestinal fibrogenesis, where novel approaches to antifibrotic strategies have been 
investigated by pharmacologic modulation of the RhoA pathway.
40
 Of interest, the enhancement of 
tissue RhoA expression, as well as the upregulation of the other molecular factors related to fibrosis 
(i.e., collagen I and III, fibronectin, vimentin), suggest that critical factors involved in fibrogenesis 
can be expressed in the advanced phases of the UC disease, also in the absence of evident strictures.  
Before moving to the conclusions of this work, we wish to address the issue of the difficulty 
in comparing data obtained from different clinical studies. In this respect, several variables of 
heterogeneity of the study populations (e.g., clinical history, histopathological lesions, disease 
activity and duration) can lead to disparate findings. The different investigated parameters, together 
with different techniques employed in different laboratories, can complicate the picture further. In 
addition, when performing retrospective investigations, as the present one, some important 
limitations depend on the availability of tissue samples, as previously reported.
9
 In particular, in the 
present study the selection of tissue specimens was made on the basis of the availability, for each 
patient, of both frozen and paraffin-embedded samples of the left colon, this limiting the choice of 
samples for our assays. 
In summary, the results of the present study indicate that an intense transmural vessel growth 
occurs in both SL- and LL-UC patients with active disease. In LL-UC patients, besides significant 
signs of fibrosis throughout the whole thickness of colonic wall and loss of elastic fibers, we 
observed a fibrotic switch of the tunica muscularis, which reduces its muscle features and acquires 
proliferative phenotypes.  
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Table 1. Pathologic and clinical characteristics of patients with short-lasting and long-lasting ulcerative 
colitis  
 
  SL-UC LL- UC P value 
Mean disease duration following diagnosis  1.82±0.32 15.90±2.57 0.0001 
Extent of colitis Ulcerative proctitis 1/9 1/10 ns 
 Left-sided UC 3/9 3/10 ns 
 Extensive UC 5/9 6/10 ns 
Histological inflammation grade  19.33±1.26  21.17±0.40 ns 
Clinical symptoms Stool frequency 2 (4/9) 2 (5/10) ns 
  3 (5/9) 3 (5/10) ns 
 Rectal bleeding 6/9 7/10 ns 
 Abdominal pain 4/9 5/10 ns 
Previous medication Prednisone 5/9 7/10 ns 
 5-ASA 4/9 5/10 ns 
 Methotrexate 1/9 2/10 ns 
 Cyclosporin 1/9 3/10 ns 
 
SL- and LL-UC, short-lasting and long-lasting ulcerative colitis; 5-ASA, 5-aminosalicylic acid; data are presented 
as mean ± SEM;  significative values, P≤0.05;ns, not significant 
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 Table 2.  Vessel density in the inflamed colon of patients with short-lasting and long-lasting ulcerative 
colitis 
 Control SL-UC LL-UC 
Vessel fraction area %     
Tunica mucosa/submucosa  6.49±0.46 13.29±0.86
a***
 15.96±1.14
a***
 
Tunica muscularis 1.11±0.13 10.62±0.80
a***
 6.45±0.35
a***,b***
 
    
Vessel length/volume     
Tunica mucosa/submucosa 9.13±1.10 18.95±1.74
a***
 16.87±1.20
a***
 
Tunica muscularis 5.87±0.68 10.58±0.42
a***
 11.66±0.76
a***
 
 
SL- and LL-UC, short-lasting and long-lasting ulcerative colitis ; a vs controls, b vs SL- 
UC, *** P≤0.001  
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FIGURE LEGENDS  
Figure 1. Increased thickness of the inflamed colonic wall in short-lasting (SL) and long-lasting 
(LL) ulcerative colitis (UC), as compared to control colon. Representative pictures of 
haematoxylin/eosin-stained samples of full-thickness, cross-sectioned left colon. CM, circular 
muscle; LM, longitudinal muscle. Scale bar: 200 μm. 
Figure 2. Proliferative microvessels in inflamed ulcerative colitis (UC). Confocal microscopy 
representative images of CD31/CD105, CD105/nestin, and PCNA/vWF double immunolabelling in 
control colon, short-lasting (SL) and long-lasting (LL) ulcerative colitis (UC). Several 
CD31/CD105-positive microvessels (v, yellowish fluorescence) together with a number of CD31-
positive very small vessels (arrows) are present in both mucosal/submucosal and muscle layers of 
inflamed colon. In control colon CD31-positive endothelial cells, which do not express any CD105, 
are found in microvessels (v) of all layers, also within a myenteric ganglionic-like cell (g) 
arrangement. In SL- and LL-UC colon, numerous microvessels (v) display CD105-positive 
endothelial cells and nestin-positive pericytes/mural cells (arrows). Note in LL-UC nestin-positive 
ganglionic cells (g). The control colon shows CD105/nestin-negative microvessels (v), which were 
revealed by a faint autofluorescence of red cells. In both SL-UC and LL-UC, double staining with 
the endothelial marker vWF and PCNA shows numerous proliferating endothelial cells (arrows). 
Scale bar 25 μm.  
Figure 3. Increased collagen fibers in inflamed long-lasting (LL) ulcerative colitis (UC). 
Representative photomicrographs of full-thickness colon showing the distribution pattern of Sirius 
Red-stained collagen fibers and Fast Green-stained non-collagen proteins in control colon, SL-UC 
and LL-UC, with respective quantification, which are expressed as percentage of positive pixels 
(PPP) calculated on the tunica mucosa/submucosa or tunica muscularis tissue area examined. 
Column graphs display the mean values of PPP±SEM; * P≤0.05; **P≤0.01. Scale bars 50μm. 
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Figure 4. Decreased elastic fibers in inflamed long-lasting (LL) ulcerative colitis (UC). 
Representative pictures of the distribution pattern of orcein-stained elastic fibers, in control colon, 
short-lasting (SL) and long-lasting (LL) UC, with respective quantification, which are expressed as 
percentage of positive pixels (PPP) calculated on the colonic whole wall tissue area examined. 
Column graph displays the mean values of PPP±SEM; **P≤0.01; ***P≤0.001. Scale bars: 50μm 
Figure 5. Increase in collagen type I and III and fibronectin in inflamed long-lasting (LL) ulcerative 
colitis (UC). Densitometric analysis of their expression in colonic mucosa and muscle layers taken 
from control subjects or patients with short-lasting (SL) and LL-UC (left panel), and representative 
examples of respective immunostaining of full-thickness left colonic slices (right panel). Each 
column represents the mean±SEM for n=5; *P≤0.05. Scale bars: 50μm. 
Figure 6. Fibrotic markers in the inflamed colon of long-lasting (LL) ulcerative colitis (UC). 
Representative Western blots showing the expression of α–SMA, vimentin, PCNA, RhoA and β-
actin and the respective densitometric analysis in colonic mucosa and muscle layers taken from 
control subjects or LL-UC patients. Each column represents the mean±SEM for n=5; *P≤0.05. 
Figure 7. Fibrotic features of the tunica muscularis in the inflamed colon of long-lasting (LL) 
ulcerative colitis (UC). Confocal microscopy representative images of colonic samples double 
immunostained for α–SMA/desmin or vimentin, and PCNA/vimentin or α–SMA. In UC colon the 
tunica muscularis shows a decrease in desmin content, better highlighted by the single channel 
(red) shown in the inset, an increment in vimentin-positive cells (inset) with several intensely 
PCNA-stained nuclei (arrows), and faintly PCNA-stained nuclei in α–SMA-positive cells (arrows). 
Scale bars: 25 μm (α–SMA/desmin or vimentin), 50 μm (PCNA/vimentin or α–SMA). 
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